DRI
53
5
MCD
52
2
ORCL
65
-2
KEY
46
3
CINF
53
2
LH
43
-2
GOOG
50
-3
FTI
81
5
WU
32
2
MSFT
50
3
WFC
79
4
MLM
57
6
AIV
72
2
KMI
67
-2
F
58
11
PSX
47
2
MCHP
41
4
NDAQ
62
2
SYY
53
4
SEE
56
6
DRI
53
5
MCD
52
2
ORCL
65
-2
KEY
46
3
CINF
53
2
LH
43
-2
GOOG
50
-3
FTI
81
5
WU
32
2
MSFT
50
3
WFC
79
4
MLM
57
6
AIV
72
2
KMI
67
-2
F
58
11
PSX
47
2
MCHP
41
4
NDAQ
62
2
SYY
53
4
SEE
56
6
Financhill
Back

ProQR Therapeutics NV Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51

PRQR
ProQR Therapeutics NV

Last Price:
3.63
Seasonality Move:
8.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

ProQR Therapeutics NV Price Quote

$3.63
+0.01 (+0.55%)
(Updated: November 23, 2024 at 5:50 AM ET)

ProQR Therapeutics NV Key Stats

Buy
51
ProQR Therapeutics NV (PRQR) is a Buy
Day range:
$3.57 - $3.68
52-week range:
$1.18 - $4.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.23
P/B ratio:
13.74%
Volume:
390.1K
Avg. volume:
2.8M
1-year change:
151.39%
Market cap:
$383.4M
Revenue:
$7.1M
EPS:
$-0.32

How Much Does ProQR Therapeutics NV Make?

Is ProQR Therapeutics NV Growing As A Company?

  • What Is ProQR Therapeutics NV's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.83%
  • What Is ProQR Therapeutics NV's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ProQR Therapeutics NV Stock Price Performance

What Is ProQR Therapeutics NV 52-Week High & Low?

ProQR Therapeutics NV Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ProQR Therapeutics NV?

Is ProQR Therapeutics NV Cash Flow Positive?

  • What Is PRQR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$35.7M
  • What Is ProQR Therapeutics NV’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2.4M
  • What Is ProQR Therapeutics NV’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $4M

ProQR Therapeutics NV Return On Invested Capital

  • Is Management Doing A Good Job?
    PRQR return on invested capital is -59.09%
  • What Is ProQR Therapeutics NV Return On Assets?
    ROA measures how assets are converting to revenues and is -19.08%
  • What Is PRQR Return On Equity?
    ROE is a measure of profitability and is -66.59%

ProQR Therapeutics NV Earnings Date & Stock Price

ProQR Therapeutics NV Competitors

ProQR Therapeutics NV Dividend Yield

ProQR Therapeutics NV Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 42.92%
Revenue: 183.35% -66.32%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 7.03
Upside from Last Price: 94.2%

Major Shareholders

  • How many PRQR shares are owned by institutional investors?
    27.1M PRQR shares are owned by institutional investors
  • How many PRQR shares are owned by insiders?
    74.5M PRQR shares are owned by insiders